About

Element Science focuses on developing health technology to address the risk of sudden cardiac arrest. Its main product, Jewel®, is a wearable defibrillator that offers continuous protection for users. Although Jewel® is not yet available for purchase in the U.S., it aims to serve individuals at risk of sudden cardiac arrest, a significant concern for millions globally. The company plans to generate revenue through the sale of these devices to individuals, healthcare providers, and insurance companies once they are commercially launched. Element Science distinguishes itself from competitors by prioritizing diversity, equity, inclusion, and belonging within its workforce, reflecting its commitment to positively impacting lives beyond just its product. Additionally, the company is focused on team expansion, which suggests potential growth and increased market presence in the medical technology sector.

Simplify's Take

What believers are saying

• The global wearable medical device market is projected to grow at a CAGR of 26.8%.
• Element Science secured $145.6 million in Series C funding, supporting product development.
• FDA's expedited approval process for digital health devices could benefit Element Science.

What critics are saying

• Delay in FDA approval could hinder Element Science's U.S. market entry and revenue.
• Intensifying competition from companies like Zoll Medical and Philips poses market challenges.
• Supply chain disruptions, especially semiconductor shortages, may delay Jewel® device production.

What makes Element Science unique

• Element Science's Jewel® defibrillator offers 24/7 protection for high-risk cardiac patients.
• The company integrates machine learning with clinical-grade wearables for personalized patient care.
• Element Science emphasizes DEIB, enhancing its workplace culture and innovation potential.

Help us improve and share your feedback! Did you find this helpful?

YesNo